UBS Group’s Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFNT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,535
Closed -$741 10500
2023
Q3
$741 Buy
+18,535
New +$2.19K ﹤0.01% 8305
2022
Q4
Sell
-493
Closed 11425
2022
Q3
$0 Sell
493
-180
-27% -$40 ﹤0.01% 11307
2022
Q2
$0 Sell
673
-55
-8% -$17 ﹤0.01% 11305
2022
Q1
$0 Buy
+728
New +$318 ﹤0.01% 11218

UBS Group's NFNT.WS Position: Q4 2023 in Review

UBS Group sold out of Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFNT.WS) in Q4 2023, closing a stake of 18,535 shares — an estimated $741 sold.

UBS Group first reported a position in NFNT.WS in Q1 2022 and held it in 4 quarters. The position peaked at $741 in Q3 2023. 0 funds tracked by Wall St. Rank hold NFNT.WS as of Q4 2023.

  • UBS Group reported no remaining Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 18,535 Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2023, an estimated $741.
  • UBS Group first reported a position in Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 4 quarters.
  • UBS Group's Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $741 in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.